TruAlt Bioenergy Q1FY27 Investor Presentation: Strong Growth in Ethanol & CBG Segments
TruAlt Bioenergy's Q1 FY27 investor presentation shows strong growth. Ethanol segment income surged 98.97% to ₹625.97 crore, with EBITDA up 263.86% to ₹126.56 crore. CBG segment income increased 10.96% to ₹11.31 crore. The company is progressing its ₹2,250 crore SAF project and expanding its retail fuel network.
The announcement details strong financial performance, strategic investments in future growth areas like SAF, and expansion plans across multiple segments. This comprehensive update provides significant insights into the company's operational and financial trajectory, impacting investor sentiment and valuation.
The company has reported significant year-on-year growth in its key segments, particularly ethanol, with strong increases in total income and EBITDA. The strategic advancements in SAF and continued expansion in CBG and retail fuel networks also contribute to a positive outlook.
TruAlt Bioenergy Limited has released its investor presentation for the quarter ended June 30, 2026 (Q1 FY27), detailing significant performance highlights and future outlook across its key business segments. The company reported robust growth in its Ethanol segment, with total income reaching ₹625.97 crore, a 98.97% increase year-on-year. EBITDA in this segment grew by 263.86% to ₹126.56 crore, with EBITDA margins improving to 20.70%. This performance is attributed to the successful integration of approximately 1,300 KLPD of dual-feed infrastructure, expanding the company's ethanol capacity to 2,000 KLPD and enabling near year-round production from diversified feedstocks.
The Compressed Biogas (CBG) segment also saw growth, with total income rising by 10.96% to ₹11.31 crore. While EBITDA saw a slight decrease of 6.16% to ₹6.24 crore due to planned maintenance and infrastructure investments, the company expects these to enhance long-term operational reliability.
TruAlt Bioenergy is strategically advancing its Sustainable Aviation Fuel (SAF) project, with an estimated investment of approximately ₹2,250 crore for a 310 KLPD Ethanol-to-SAF facility. The company is progressing through engineering, approvals, and stakeholder engagement, aiming for financial closure and commissioning within 24-30 months, supported by a ₹150 crore grant under the PM JI-VAN Yojana.
The Retail Fuel Network is expanding cautiously, with 7 outlets operational and 4 more under construction as part of a 100-outlet rollout strategy. The company reported total income of ₹4.40 crore in this segment.
Mr. Vijay Nirani, Managing Director, highlighted the company's strong performance as a listed entity and its commitment to disciplined execution and sustainable growth across its integrated clean energy platform, spanning ethanol, CBG, SAF, and fuel retailing.
What to do with a filing like this
TruAlt Bioenergy Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by TruAlt Bioenergy Limited. Read the original for the full detail.